BIOMAT Database Logo BIOMAT Database Logo

Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents. 2004

Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Dipartimento Farmaco-Chimico, Università di Messina, viale Annunziata, 98168, Messina, Italy.

Several 2,3-diaryl-1,3-thiazolidin-4-ones were synthesized and evaluated as anti-HIV agents. The results of the in vitro tests showed that some of them were highly effective inhibitors of HIV-1 replication at 30-50 nM concentrations with minimal cytotoxicity, thereby acting as non-nucleoside HIV-1 reverse transcriptase inhibitors (NNRTIs).

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669

Related Publications

Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Synthesis and biological evaluation of 2,3-diaryl substituted-1,3-thiazolidin-4-ones as anti-HIV agents.
July 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones.
February 2003, Farmaco (Societa chimica italiana : 1989),
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Microwave-assisted synthesis and anti-YFV activity of 2,3-diaryl-1,3-thiazolidin-4-ones.
September 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-(thi)one derivatives.
September 2002, Farmaco (Societa chimica italiana : 1989),
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Predicting anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones: computational approach using reformed eccentric connectivity index.
December 2004, Journal of molecular modeling,
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
April 2016, Bioorganic & medicinal chemistry letters,
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. II. Biological activity of chlorinated 2,3-diaryl-1,3-thiazolidin-4-ones.
February 1989, Bollettino della Societa italiana di biologia sperimentale,
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. III. Biological activity of halogenated 2,3-diaryl-1,3-thiazolidin-4-ones.
June 1989, Bollettino della Societa italiana di biologia sperimentale,
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
December 2008, European journal of medicinal chemistry,
Angela Rao, and Jan Balzarini, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
February 2007, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!